Last reviewed · How we verify
NCT06790992
Relıabılıty and valıdıty of the supıne-to-stand Test wıth Multiple Sclerosis
trial in Multiple Sclerosis in 34 participants. Completed in 1 November 2024.
1 September 2024
Quick facts
| Lead sponsor | Sanko University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 34 |
| Start date | 1 August 2024 |
| Primary completion | 1 September 2024 |
| Estimated completion | 1 November 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Sanko University
Who can join
Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Supine-to-Stand Test (SST) requires muscle strength, flexibility, and dynamic balance and can be used as a marker of functional motor competence in patients with Multiple Sclerosis (pwMS). Objectives: To investigate the reliability and validity of SST in pwMS. Methods: Muscle strength was measured using digital goniometer for plantar and dorsiflexor in pwMS (n=44). Manual dexterity was assessed through the 9-hole Peg Test (9HPT). Balance was evaluated using with Berg Balance Test (BBT). Walking speed was assessed using Six-minute Walk test (6MWT). Timed up and go test (TUG), Activity-spesific Balance Confidence scale was used for fear of falling. Quality of life was assessed with MSQOL-54. Results: The test's intraclass correlation was 0.984 (95% CI 0.801-0.995). Significant moderate correlations were found between SST and BBT (r=-0.547, p=0.001), TUG (r=0.619, p\<0.001), and 6MWT (r=-0.642, p\<0.001). A moderate correlation was also found between dominant side plantar flexor strength and SST (r=0.349, p=0.043), but not non-dominant side and bilaterally dorsi flexors (p\>0.05). Additionally, no significant correlation was found between SST and bilaterally 9HPT, MSQOL-54 (p\>0.05). Conclusion: This study establishes SST as a reliable and valid tool for assessing functional motor competence in pwMS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06790992
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Sanko University trials
Trials by the same sponsor.
- NCT07462338 — Validity and Reliability of Timed Up and Go Test in Dual-Task Conditions for Multiple Sclerosis Patients · enrolling by invitation
- NCT07454655 — The Effect of Percussion Massage Therapy in Stroke Patients · NA · enrolling by invitation
- NCT07435116 — Duchenne Muscular Dystrophy and the Viscoelastic Properties of Upper Limb Muscles · enrolling by invitation
- NCT07441213 — Viscous Elastic Properties of Superficial Back Muscles in Individuals With Hyperkyphosis · completed
- NCT07422064 — Validity and Reliability of the Six-Minute Pegboard Ring Test in Individuals With Parkinson's Disease · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06790992 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sanko University
- Last refreshed: 24 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06790992.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing